“Inovio has launched preclinical testing for clinical product manufacturing. INO-4800 development is also supported now by a recent $9.2 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI).” – GEN News
With CEPI awarding a large amount of their remaining donation funds to Inovio, it is clear that Switzerland has selected this bio-tech company as the horse that will win this race for the Coronavirus vaccine.
Coalition for Epidemic Preparedness Innovations has been on the forefront of vaccine research since the start of the pandemic. Many experts have been waiting on their decisions on which labs to expect progress from and which labs are showing little to no data of improvement.
With this endorsement Inovio should, by this time next year, be one of the biggest bio tech labs in the country.